Brainomix Honored for Revolutionary Advances in AI Imaging Technology

Brainomix Honored for Revolutionary Advances in AI Imaging Technology

Brainomix’s groundbreaking AI imaging solutions have earned the company two prestigious accolades in 2024, cementing its position as a leader in healthtech innovation. The company received the LSX European Lifestars Award for “Healthtech Company of the Year” by HSBC Innovation Banking and the “Most Transformative Healthtech Company of the Year” by OBN. These awards highlight Brainomix’s significant contributions to improving patient care globally.

The recognition underscores Brainomix’s success in the past year, including endorsements by the National Institute for Health & Care Excellence (NICE) and multiple FDA approvals for its stroke and lung fibrosis imaging technologies. These advancements have not only propelled the company’s expansion into the U.S. market but also enhanced its ability to deliver life-saving treatment solutions.

Revolutionizing Stroke Treatment with AI
The Brainomix 360 Stroke platform has been a game-changer in the field of stroke care. At the European Stroke Organisation Conference (ESOC) in Basel this year, a large-scale real-world evaluation demonstrated that the use of Brainomix 360 Stroke resulted in a 50% increase in the number of patients eligible for mechanical thrombectomy. This life-saving procedure can significantly reduce disability and long-term care needs for patients suffering from severe strokes caused by large vessel blockages.

Countries like Hungary and Wales have adopted Brainomix’s technology nationwide, leading to remarkable improvements in stroke care. Hungary reported a 50% increase in thrombectomy rates across 28 national sites, while Wales saw an impressive 44% surge in the procedure. As Dr. Shakeel Ahmad, National Clinical Lead for Stroke in Wales, stated, “The Brainomix 360 Stroke platform enables faster, more precise decision-making, which improves outcomes for stroke patients no matter where they live.”

Expanding Global Reach and Patient Impact
Brainomix’s AI-powered imaging tools are setting new standards in healthcare innovation. By leveraging simple brain scans, the technology generates critical insights and provides a secure platform for clinicians to share analysis and images efficiently. This streamlined approach has made it easier to diagnose and treat conditions like stroke and lung fibrosis, ensuring more patients receive timely and effective care.

As part of its ongoing mission, Brainomix continues to develop cutting-edge AI solutions that expand access to life-saving treatments. This commitment reflects the broader trend of AI reshaping healthcare workflows, a transformation that has also been noted in Microsoft and Viz.ai’s partnership to enhance AI-driven healthcare efficiency.

With its innovative approach and dedication to improving global health outcomes, Brainomix is poised to lead the next wave of advancements in AI-powered medical technology.

On Key

Related Posts

stay in the loop

Get the latest AI news, learnings, and events in your inbox!